chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: HARD TO BREATHE; INCREASE HEART RATE; WHEEZING; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included allergic to sulfa antibiotics, and non-smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 18:00 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced hard to breathe. On 01-APR-2021, the subject experienced increase heart rate. On 01-APR-2021, the subject experienced wheezing. Laboratory data included: Heart rate (NR: not provided) 104-114, Potassium (NR: not provided) Low, and SARS-CoV-2 test (NR: not provided) unknown. Treatment medications (dates unspecified) included: diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from hard to breathe, increase heart rate, and wheezing. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808609, expiry: not reported) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeling hot, Flushing
Clinical narrative: WATER IN EAR TYPE DIZZINESS; FLUSHING; WARM FEELING; CHILLS; TIREDNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's past medical history included geographic tongue, and concurrent conditions included steroids allergy, and body does not react well to foreign substances. The patient experienced geographic tongue when treated with levofloxacin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced flushing. On 05-APR-2021, the subject experienced warm feeling. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced tiredness. On 05-APR-2021 15:00, the subject experienced water in ear type dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from water in ear type dizziness on 05-APR-2021 15:40, and flushing, warm feeling, chills, and tiredness on 07-APR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity, Suspected COVID-19
Clinical narrative: POSSIBLE COVID-19 INFECTION; PAIN IN ARM; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 06-APR-2021 15:00 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On APR-2021, the subject experienced pain in arm.  On 06-APR-2021, the subject experienced possible covid-19 infection. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the possible covid-19 infection and pain in arm was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Insomnia, Nausea, Vaccination site pain
Clinical narrative: FELT SORE IN THE SHOT LOCATION; NAUSEA; DIZZINESS; COULD NOT SLEEP BECAUSE OF NAUSEA; This spontaneous report received from a patient concerned a 45 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 12:45 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced could not sleep because of nausea. On 07-APR-2021 14:00, the subject experienced dizziness. On 07-APR-2021 14:00, the subject experienced nausea. On 08-APR-2021, the subject experienced felt sore in the shot location. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizziness, had not recovered from nausea, and felt sore in the shot location, and the outcome of could not sleep because of nausea was not reported. This report was non-serious.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Headache, Paraesthesia, Pyrexia
Clinical narrative: SKIN FEELS SENSITIVE/TINGLING; SKIN FEELS SENSITIVE/TINGLING; FEELS LIGHTHEADED; HEADACHE; FEVER 102 DEGREES; This spontaneous report received from a patient concerned a 19 year old male. The patient's weight was 125 pounds, and height was 67 inches. The patient's concurrent conditions included non smoker, abstains from alcohol, and penicillin allergy, and other pre-existing medical conditions included patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced skin feels sensitive/tingling. On 08-APR-2021, the subject experienced feels lightheaded. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever 102 degrees. On 08-APR-2021, the subject experienced skin feels sensitive/tingling. Laboratory data included: Body temperature (NR: not provided) 102 deg, and COVID-19 virus test negative (NR: not provided) Negative. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, skin feels sensitive/tingling, feels lightheaded, fever 102 degrees, and skin feels sensitive/tingling. This report was non-serious.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Sensitive skin
Clinical narrative: SKIN FEELS SENSITIVE/TINGLING; SKIN FEELS SENSITIVE/TINGLING; FEELS LIGHTHEADED; HEADACHE; FEVER 102 DEGREES; This spontaneous report received from a patient concerned a 19 year old male. The patient's weight was 125 pounds, and height was 67 inches. The patient's concurrent conditions included non smoker, abstains from alcohol, and penicillin allergy, and other pre-existing medical conditions included patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced skin feels sensitive/tingling. On 08-APR-2021, the subject experienced feels lightheaded. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever 102 degrees. On 08-APR-2021, the subject experienced skin feels sensitive/tingling. Laboratory data included: Body temperature (NR: not provided) 102 deg, and COVID-19 virus test negative (NR: not provided) Negative. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, skin feels sensitive/tingling, feels lightheaded, fever 102 degrees, and skin feels sensitive/tingling. This report was non-serious.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: ADMINISTERED VACCINE OUT OF TEMPERATURE RANGE; This spontaneous report received from a pharmacist concerned an 18 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced administered vaccine out of temperature range. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administered vaccine out of temperature range was not reported. This report was non-serious. This case, from the same reporter is linked to 20210343668.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper
Clinical narrative: STOMACH PAIN; This spontaneous report received from a parent concerned an 18 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced stomach pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of stomach pain was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain
Clinical narrative: BODY ACHES; CHILLS; EXTREME TIREDNESS; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 09:00 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced extreme tiredness. On 08-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, body aches, extreme tiredness and headache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Injection site pain, Pyrexia
Clinical narrative: TEMPERATURE OF 103.3; PAIN AT THE INJECTION SITE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced temperature of 103.3. On 08-APR-2021, the subject experienced pain at the injection site. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 103.3 deg. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from temperature of 103.3, and the outcome of pain at the injection site was not reported. This report was non-serious.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Nausea, Pain
Clinical narrative: MUSCLE ACHES IN SHOULDER AND LEGS; TIREDNESS; FELT LIKE VOMITING; BODY ACHES; This spontaneous report received from a patient concerned an elderly male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry: 26-MAY-2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced felt like vomiting. On 06-APR-2021 21:00, the subject experienced tiredness. On 07-APR-2021, the subject experienced muscle aches in shoulder and legs. On 08-APR-2021, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and muscle aches in shoulder and legs on 09-APR-2021, tiredness on 07-APR-2021, and felt like vomiting on 06-APR-2021. This report was non-serious.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dyspepsia, Pyrexia, Rash
Clinical narrative: INDIGESTION; GENERALIZED JOINT PAIN; FEVER; RAISED RASH ON RIGHT LEG; This spontaneous report received from a patient concerned a 65 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included osteoporosis, mitral valve prolapse, and penicillin allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported.  On 06-APR-2021, the subject experienced raised rash on right leg. On 06-APR-2021, the subject experienced fever. On 06-APR-2021 15:00, the subject experienced generalized joint pain. On 06-APR-2021 19:00, the subject experienced indigestion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 06-APR-2021, and had not recovered from indigestion, generalized joint pain, and raised rash on right leg. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Vomiting
Clinical narrative: VOMITING/CAN'T KEEP ANYTHING DOWN; SWEATING; CHILLS; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) frequency 1 total, dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 08-APR-2021, the subject experienced vomiting/can't keep anything down. On 08-APR-2021, the subject experienced sweating. On 08-APR-2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, vomiting/can't keep anything down, and sweating. This report was non-serious.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: NAUSEA; FATIGUE; This spontaneous report received from a patient concerned a 47 year old. The patient's height, and weight were not reported. The patient's concurrent conditions included high blood pressure, and environmental allergy, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: UNKNOWN) dose was not reported, 1 total, administered on 08-APR-2021 09:00 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced nausea. On 08-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea, and fatigue. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Bone pain, Chills, Insomnia, Malaise
Clinical narrative: MIGRAINE HEADACHE; CHILLS; NOT FEELING GOOD; FEVER; BONES ACHE; DIFFICULTY SLEEPING; This spontaneous report received from a consumer concerned a 45 year old female. The patient's height, and weight were not reported. The patient's past medical history included hysterectomy, and gall bladder disorder, and concurrent conditions included migraine, and cigarette smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 17:30 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced bones ache. On 10-APR-2021, the subject experienced migraine headache. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced not feeling good. On 10-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. On 10-APR-2021 10:00, Laboratory data included: Body temperature (NR: not provided) 99.4 F. On an unspecified date, the subject experienced difficulty sleeping. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, bones ache, migraine headache, and chills, and the outcome of not feeling good and difficulty sleeping was not reported. This report was non-serious.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pyrexia
Clinical narrative: MIGRAINE HEADACHE; CHILLS; NOT FEELING GOOD; FEVER; BONES ACHE; DIFFICULTY SLEEPING; This spontaneous report received from a consumer concerned a 45 year old female. The patient's height, and weight were not reported. The patient's past medical history included hysterectomy, and gall bladder disorder, and concurrent conditions included migraine, and cigarette smoker, and other pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 17:30 for prophylactic vaccination. No concomitant medications were reported. On 10-APR-2021, the subject experienced bones ache. On 10-APR-2021, the subject experienced migraine headache. On 10-APR-2021, the subject experienced chills. On 10-APR-2021, the subject experienced not feeling good. On 10-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 101 F. On 10-APR-2021 10:00, Laboratory data included: Body temperature (NR: not provided) 99.4 F. On an unspecified date, the subject experienced difficulty sleeping. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, bones ache, migraine headache, and chills, and the outcome of not feeling good and difficulty sleeping was not reported. This report was non-serious.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Neurological symptom, Pain, Tremor
Clinical narrative: BODY ACHES; SHAKING; NEUROLOGICAL SYMPTOMS; HEADACHE; This spontaneous report received from a patient concerned a 22 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy to antibiotic, abstains from alcohol, and non-smoker, and other pre-existing medical conditions included patient had no drug abuse or illicit drug.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 06-APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced shaking. On 06-APR-2021, the subject experienced neurological symptoms. On 06-APR-2021, the subject experienced headache. On 06-APR-2021 17:00, treatment medications included: ibuprofen, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, shaking, neurological symptoms, and headache on 06-APR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Chills, Cough, Dizziness
Clinical narrative: CHEST COUGH; UPSET STOMACH; CHILLS; HEADACHE; FEVER; DIZZINESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 01-APR-2021, the subject experienced dizziness. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fever. On an unspecified date, the subject experienced chest cough, and upset stomach. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.5 F, 97.4 F, and Lung function tests (NR: not provided) Clear. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizziness, chills, headache, fever, chest cough, and upset stomach. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pulmonary function test, Pyrexia
Clinical narrative: CHEST COUGH; UPSET STOMACH; CHILLS; HEADACHE; FEVER; DIZZINESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 01-APR-2021, the subject experienced dizziness. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fever. On an unspecified date, the subject experienced chest cough, and upset stomach. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.5 F, 97.4 F, and Lung function tests (NR: not provided) Clear. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizziness, chills, headache, fever, chest cough, and upset stomach. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dizziness, Fatigue, Headache
Clinical narrative: COUGH; LIGHT HEADEDNESS / DIZZY; CHILLS; HEADACHE; FEVER; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 0428218, expiry: not reported) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 07-APR-2021, the subject experienced cough. On 07-APR-2021, the subject experienced light headedness / dizzy. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, headache, and fatigue on APR-2021, was recovering from fever, and light headedness / dizzy, and had not recovered from cough. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: COUGH; LIGHT HEADEDNESS / DIZZY; CHILLS; HEADACHE; FEVER; FATIGUE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 0428218, expiry: not reported) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 07-APR-2021, the subject experienced cough. On 07-APR-2021, the subject experienced light headedness / dizzy. On 07-APR-2021, the subject experienced chills. On 07-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, headache, and fatigue on APR-2021, was recovering from fever, and light headedness / dizzy, and had not recovered from cough. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Pain assessment, Skin warm
Clinical narrative: WARM TO TOUCH; SORENESS ON THE LEFT ARM (INJECTION SITE)/SORE; This spontaneous report received from a patient concerned a 22 year old male. The patient's weight was 125 kilograms, and height was 170 centimeters. The patient's concurrent conditions included alcoholic, non-smoker, and herpes, and other pre-existing medical conditions included patient had no known allergies, no drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 205A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-APR-2021, the subject experienced warm to touch. On 09-APR-2021, the subject experienced soreness on the left arm (injection site).  Laboratory data included: Pain scale (NR: not provided) 4/10 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from soreness on the left arm (injection site), and the outcome of warm to touch was not reported. This report was non-serious.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph node in left armpit
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Injection site pain, Injection site swelling
Clinical narrative: Swelling of injection site, medium size nodules around vaccine site, left arm shooting pain 7 days post vaccine
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Electrocardiogram normal, Fluid retention, Headache, Injection site pain
Clinical narrative: I received the vaccine on March 24, on a Blue Day, when I was physically at work.  I stayed in the office until 5:00 pm and felt normal.  I could feel the place of the injection, but that was all.   The next day, March 25, I worked from home.  I woke up with a medium pain in the arm at the place of the injection and with a headache.  I said to myself, these are normal reactions following the vaccine.  The headache did not go away, although I took a Ibuprofen rapid tablet of 400 mg.  In the afternoon I checked my blood pressure and it was 171/90 and the pulse 86.  I took immediately additional blood pressure medicine (Captopril and Tertensif) to lower it.  In 2 hours it lowered it to 166/89 P81, at the advice of my physician, whom I called, I took the medicine I take for blood pressure Atacand and a pill to eliminate the water in the body.  Finally at 9:00 pm the blood pressure measured 149/81 P71.   On March 26 I came to work, with my blood pressure device, and at noon it was 198/94 P95.  I took two pills of Atacand and Furosemid and I came to the physician measured a blood pressure of 159/95, and subsequently 144/86.  She did an EKG which was normal.   On March 27, Saturday the blood pressure ranged between 132/74 P72 in the morning and 104/60 P 65 in the evening, taking only my usual medication for blood pressure.  And since then my blood pressure returned to normal taking only my usual treatment.      On March 29 I went to my cardiologist who examined me and did not find anything out of the ordinary, told me to continue with the same treatment, and monitor the blood pressure twice a day.  She of course, as anyone else, could not say it was due to the vaccine, but she could not dismiss the fact that maybe the vaccine had an influence over the blood pressure.  She encouraged me to take also the second dose of the vaccine.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Lymphadenopathy
Clinical narrative: 2nd dose of vaccine very painful arm and large red , hot area  at injection site., beginning the evening of the shot.  Much worse than the original injection.  Painful swollen lymph node in same arm.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus started on the third evening following the vaccine. It's so loud that it's preventing me from sleeping.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Granuloma annulare
Clinical narrative: Granuloma annulare Appeared 4/12/21 No pain
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling hot, Influenza like illness, Malaise
Clinical narrative: I had received the vaccine on April 12, 2021 at 11:30am.  I felt a warm sensation go down my arm when I received the vaccine. No ill effects however.  Around 2:30am the following morning (April 13, 2021) I started feeling ill. I had flu-like symptoms including: body aches, chills, fatigue, etc. I did not take my temperature, however, I believe I was feverish. I took 400mg of Ibuprofen around 11:30am (24 hours after receiving the vaccine). After sleeping for 2 hours, I began feeling better.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: I had received the vaccine on April 12, 2021 at 11:30am.  I felt a warm sensation go down my arm when I received the vaccine. No ill effects however.  Around 2:30am the following morning (April 13, 2021) I started feeling ill. I had flu-like symptoms including: body aches, chills, fatigue, etc. I did not take my temperature, however, I believe I was feverish. I took 400mg of Ibuprofen around 11:30am (24 hours after receiving the vaccine). After sleeping for 2 hours, I began feeling better.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Initial erythematous, pruritic rash over injection site lasting days 1-3 after injection. Rash recurred day 8 after injection in same distribution - this time papular and pruritic.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Blood pressure abnormal, Chills, Condition aggravated, Headache
Clinical narrative: She said that the onset of the symptoms was 2-3 hours after the vaccination, and 4 hours later she developed some allergic reaction and hives (  at the temple). Other symptoms were loss of equilibrium, chills and pain in the back of the head at the nape of the neck, also low grade fever 37.5°C.  She had a HTN 180/90 mmHg, but she has a history of HTN and currently is taking Enalapril 10 mg/ day. She is taking also some supplements Vit C and vitamin D but not constantly, that day she did not take it. She woke up during the night and took the medication for high blood pressure, the next day the blood pressure normalized. She is allergic to  some foods, for example strawberries , propolis and some of the anti-inflammatories such us Ibuprofen. Took an antiallergic  in the evening ? Xyzal- 1tab.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Neck pain, Pyrexia, Urticaria
Clinical narrative: She said that the onset of the symptoms was 2-3 hours after the vaccination, and 4 hours later she developed some allergic reaction and hives (  at the temple). Other symptoms were loss of equilibrium, chills and pain in the back of the head at the nape of the neck, also low grade fever 37.5°C.  She had a HTN 180/90 mmHg, but she has a history of HTN and currently is taking Enalapril 10 mg/ day. She is taking also some supplements Vit C and vitamin D but not constantly, that day she did not take it. She woke up during the night and took the medication for high blood pressure, the next day the blood pressure normalized. She is allergic to  some foods, for example strawberries , propolis and some of the anti-inflammatories such us Ibuprofen. Took an antiallergic  in the evening ? Xyzal- 1tab.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Activated partial thromboplastin time, Blood gases, Cardio-respiratory arrest, Chest X-ray abnormal, Chest pain
Clinical narrative: Pt received vaccination. Pt reports that she started feeling more fatigued and short of breath the week following injection. However,  on 09Apr2021 pt had increased SOB and chest pain while shower, went into the doctor. After scan discovered Massive PE. Pt decompensated quickly and required intubation. Upon transfer to medical center, there were complications with ET tube and pt coded and required resuscitation for 6 minutes. Pt recovered and was transferred. Pt had Chest Xray, doppler of Blilateral lower extremities. Confirming PE and also left Popliteal DVT. Pt was on heparin drip which was switched to lovenox for proper anticoagulation.  Pt was extubated on the 11th, is recovering. .
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Deep vein thrombosis, Dyspnoea, Endotracheal intubation, Endotracheal intubation complication
Clinical narrative: Pt received vaccination. Pt reports that she started feeling more fatigued and short of breath the week following injection. However,  on 09Apr2021 pt had increased SOB and chest pain while shower, went into the doctor. After scan discovered Massive PE. Pt decompensated quickly and required intubation. Upon transfer to medical center, there were complications with ET tube and pt coded and required resuscitation for 6 minutes. Pt recovered and was transferred. Pt had Chest Xray, doppler of Blilateral lower extremities. Confirming PE and also left Popliteal DVT. Pt was on heparin drip which was switched to lovenox for proper anticoagulation.  Pt was extubated on the 11th, is recovering. .
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Extubation, Fatigue, Full blood count, International normalised ratio, Metabolic function test
Clinical narrative: Pt received vaccination. Pt reports that she started feeling more fatigued and short of breath the week following injection. However,  on 09Apr2021 pt had increased SOB and chest pain while shower, went into the doctor. After scan discovered Massive PE. Pt decompensated quickly and required intubation. Upon transfer to medical center, there were complications with ET tube and pt coded and required resuscitation for 6 minutes. Pt recovered and was transferred. Pt had Chest Xray, doppler of Blilateral lower extremities. Confirming PE and also left Popliteal DVT. Pt was on heparin drip which was switched to lovenox for proper anticoagulation.  Pt was extubated on the 11th, is recovering. .
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Prothrombin time, Pulmonary embolism, Resuscitation, SARS-CoV-2 test, Troponin
Clinical narrative: Pt received vaccination. Pt reports that she started feeling more fatigued and short of breath the week following injection. However,  on 09Apr2021 pt had increased SOB and chest pain while shower, went into the doctor. After scan discovered Massive PE. Pt decompensated quickly and required intubation. Upon transfer to medical center, there were complications with ET tube and pt coded and required resuscitation for 6 minutes. Pt recovered and was transferred. Pt had Chest Xray, doppler of Blilateral lower extremities. Confirming PE and also left Popliteal DVT. Pt was on heparin drip which was switched to lovenox for proper anticoagulation.  Pt was extubated on the 11th, is recovering. .
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: Pt received vaccination. Pt reports that she started feeling more fatigued and short of breath the week following injection. However,  on 09Apr2021 pt had increased SOB and chest pain while shower, went into the doctor. After scan discovered Massive PE. Pt decompensated quickly and required intubation. Upon transfer to medical center, there were complications with ET tube and pt coded and required resuscitation for 6 minutes. Pt recovered and was transferred. Pt had Chest Xray, doppler of Blilateral lower extremities. Confirming PE and also left Popliteal DVT. Pt was on heparin drip which was switched to lovenox for proper anticoagulation.  Pt was extubated on the 11th, is recovering. .
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Arthralgia, Chills, Dizziness, Fatigue
Clinical narrative: headache, dizziness, nausea, fatigue, sweating, extreme abdominal pain, intolerable nausea, vomitting, chills, body aches, extreme knee pain  treatment - ibuprofen 600 mg every 4 hours
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hyperhidrosis, Nausea, Pain, Vomiting
Clinical narrative: headache, dizziness, nausea, fatigue, sweating, extreme abdominal pain, intolerable nausea, vomitting, chills, body aches, extreme knee pain  treatment - ibuprofen 600 mg every 4 hours
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Injection site warmth
Clinical narrative: Hard/thick skin, warm to the touch, itchy - about 2 inches in diameter at site of vaccine
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Sleep disorder
Clinical narrative: Extreme fatigue started about 5 hours after innoculation, followed by chills (no fever), all over body aches, vise-like headache, and inability to sleep. Pulse and oxygen levels measured by fingertip oximeter were within normal range.  Symptoms peaked at 16-24 hours, and were mostly gone in 48 hours. Lingering headache for another 12 hours or so.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Rash, Rash erythematous, Rash pruritic
Clinical narrative: FEVER and RED RASH by next morning.  treated with Tylenol and Aleve: FEVER went away after approximately 24 hours. RASH HAS REMAINED STILL (minor itching only) RASH has faded from the torso but remains on the legs and feet, Rash does seem to be fading a little every day
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Fever 99 Chills Full Body Muscle Aches Head to Toe Nausea Fatigue Headache April 10 10:00pm - April 13 10:00am
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: Fever 99 Chills Full Body Muscle Aches Head to Toe Nausea Fatigue Headache April 10 10:00pm - April 13 10:00am
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Feeling nauseous.   Did not eat breakfast this a.m. V/S  B/P 124/50, HR 60, O2Sat 100%; 11:38am Pt. left at 11:38am verbalized that she is feeling better.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dyspnoea, Headache, Hyperhidrosis
Clinical narrative: FELT HARDER TO BREATHE WITH MASK; JOINT PAIN ALL OVER; CHILLS; FEVER; MASSIVE HEADACHE; SWEATING; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included bypass surgery, and blood clots, and concurrent conditions included non smoker. The patient experienced itching and rash when treated with heparin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: not reported) dose was not reported, administered on 07-APR-2021 15:00 to Left Arm for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 08-APR-2021, the subject experienced sweating. On 08-APR-2021, the subject experienced joint pain all over. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced massive headache. On 09-APR-2021, the subject experienced felt harder to breathe with mask. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, joint pain all over, chills, fever, and massive headache on 08-APR-2021, and the outcome of felt harder to breathe with mask was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FELT HARDER TO BREATHE WITH MASK; JOINT PAIN ALL OVER; CHILLS; FEVER; MASSIVE HEADACHE; SWEATING; This spontaneous report received from a patient concerned a 42 year old female. The patient's height, and weight were not reported. The patient's past medical history included bypass surgery, and blood clots, and concurrent conditions included non smoker. The patient experienced itching and rash when treated with heparin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: not reported) dose was not reported, administered on 07-APR-2021 15:00 to Left Arm for prophylactic vaccination. Concomitant medications included acetylsalicylic acid for drug used for unknown indication. On 08-APR-2021, the subject experienced sweating. On 08-APR-2021, the subject experienced joint pain all over. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced massive headache. On 09-APR-2021, the subject experienced felt harder to breathe with mask. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating, joint pain all over, chills, fever, and massive headache on 08-APR-2021, and the outcome of felt harder to breathe with mask was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Pyrexia, Rash pruritic
Clinical narrative: HEADACHE; INJECTION SITE SORENESS; RASH ALL OVER THE BODY AND STILL SPREADING, VERY ITCHY; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included cranberry allergy, multiple sclerosis, drinks alcohol occasionally, and non smoker, and other pre-existing medical conditions included the patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, the subject experienced fever. Treatment medications included: calamine/glycerol/zinc oxide, and paraffin. On 19-MAR-2021, the subject experienced rash all over the body and still spreading very itchy. On 19-MAR-2021, the subject experienced injection site soreness. On 21-MAR-2021, the subject experienced headache. Additional treatment medications (dates unspecified) included: cortisone. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever, and injection site soreness on 2021, had not recovered from rash all over the body and still spreading very itchy, and the outcome of headache was not reported. This report was non-serious.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Diarrhoea, Dizziness, Fatigue
Clinical narrative: BODY ACHES; LIGHT HEADEDNESS; DIARRHEA; FULL BLOWN FLU; CHILLS; HEADACHE; NAUSEA; FATIGUE; APPETITE LOST; This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cigarette smoker, and other pre-existing medical conditions included the patient has no known allergies. The patient was previously treated with escitalopram, atorvastatin calcium, and vitamins nos. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031,expiry:UNKNOWN) dose was not reported, administered on 11-MAR-2021 16:30 for prophylactic vaccination. Concomitant medications included alprazolam, and nicotine. On 11-MAR-2021, the subject experienced appetite lost. On 11-MAR-2021, the subject experienced fatigue. On 12-MAR-2021 02:30, the subject experienced body aches. On 12-MAR-2021 02:30, the subject experienced light headedness. On 12-MAR-2021 02:30, the subject experienced diarrhea. On 12-MAR-2021 02:30, the subject experienced full blown flu. On 12-MAR-2021 02:30, the subject experienced chills. On 12-MAR-2021 02:30, the subject experienced headache. On 12-MAR-2021 02:30, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, light headedness, diarrhea, full blown flu, appetite lost, chills, headache, and nausea on 18-MAR-2021, and had not recovered from fatigue. This report was non-serious.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Nausea, Pain
Clinical narrative: BODY ACHES; LIGHT HEADEDNESS; DIARRHEA; FULL BLOWN FLU; CHILLS; HEADACHE; NAUSEA; FATIGUE; APPETITE LOST; This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cigarette smoker, and other pre-existing medical conditions included the patient has no known allergies. The patient was previously treated with escitalopram, atorvastatin calcium, and vitamins nos. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031,expiry:UNKNOWN) dose was not reported, administered on 11-MAR-2021 16:30 for prophylactic vaccination. Concomitant medications included alprazolam, and nicotine. On 11-MAR-2021, the subject experienced appetite lost. On 11-MAR-2021, the subject experienced fatigue. On 12-MAR-2021 02:30, the subject experienced body aches. On 12-MAR-2021 02:30, the subject experienced light headedness. On 12-MAR-2021 02:30, the subject experienced diarrhea. On 12-MAR-2021 02:30, the subject experienced full blown flu. On 12-MAR-2021 02:30, the subject experienced chills. On 12-MAR-2021 02:30, the subject experienced headache. On 12-MAR-2021 02:30, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, light headedness, diarrhea, full blown flu, appetite lost, chills, headache, and nausea on 18-MAR-2021, and had not recovered from fatigue. This report was non-serious.